...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Interesting read on the backlash to FDA's approval of aducanumab

A review of the BET on Mace findings from Dec 6th, 2019 presentation.

Slide 11 gives the outline.


https://www.resverlogix.com/upload/media_element/204/0e211c4026d8/betonmace-cognitive-assessment-results.pdf

 

tada 

Share
New Message
Please login to post a reply